FDA-Inspected Site

The Harvard Drug Group LLC

5 FDA inspections are on record for The Harvard Drug Group LLC in La Vergne, United States.

483· Form 483 issued

La Vergne, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-03-20.

At a glance

Inspections

5

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Mar 2026 – 20 Mar 2026Human Drugs483View 483 →
18 Feb 2020 – 6 Mar 2020Human Drugs483On file
27 Oct 2016 – 1 Nov 2016Human DrugsClean
18 Mar 2008Not recordedClean
18 Nov 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

20 Mar 2026
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Demario L Walls, Sarah E Venti, Nelson N Ayangho

20 Mar 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Demario L Walls, Sarah E Venti, Nelson N Ayangho

20 Mar 2026
FDCA 582(b)(4)

Systems in place to comply with verification requirements

Cited by Demario L Walls, Sarah E Venti, Nelson N Ayangho

Investigators

FDA investigators tied to this site in the record.

Nelson N Ayangho1 insp.
Bei Y He1 insp.
Patsy J Domingo1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
FDCA 582(b)(4)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind The Harvard Drug Group LLC's 2 Form 483s

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat